Klixar’s first project was a vaccine trial (phase II in patients in ICU) and since then developed into a solid company with a proven track record of successful clinical trials (many of which were rescue studies) conducted not only in Argentina but also in Brazil, Colombia, Mexico and Perú.
Phone: +5411, 4788-9191
E-mail: hello@klixar.com
Web: http://www.klixar.com
Add:Ciudad de la Paz 1887 1º B C1428CPC – CABA, Argentina
想要下载更多资料,请您添加微信了解详情!
微信号:csco2022
公众号:康安医药咨询